Safety and efficacy of autologous and metabolically fit bone marrow mesenchymal stromal cells (BM-MSC) in medically refractory crohn's disease (CD)

Category Primary study
JournalCytotherapy
Year 2016
This article has no abstract
Epistemonikos ID: 1b58e0d86f174991f7c7d66fc0aa60052f2fc9b2
First added on: Feb 07, 2025